Weekly Executive & Director Moves (Aug 19)

by | Aug 19, 2022

Boardroom Alpha provides in-depth analytics and tracking of all public company executives and officers. Below is a rundown of people moves made at notable companies this past week. Get a demo today to see how you can receive real-time alerts and in-depth analytics.

Moves in this Issue

CEO

NWBI, TTNP

CFO

ADT, BKD, BMTM, CECE, COLI, CTOS, FBIO, HSC, MINM, MRNA, NFNT, RIOT, SDGR, SLNH

Directors

AKUS, ALV, BIRD, BOX, BR, FHTX, FLS, FTHM, GM, HLGN, JJSF, LC, M, MGTA, MKSI, MNKKQ, NEO, NNN, NWBI, ONEW, PAA, PAGP, PYXS, PYXSQ, SAIL, SHLS, SJM, SLS, TPTX, TTNP, VNRX, VYGR, WATT, WEAV, ZIP

CEO Moves

NORTHWEST BANCSHARES INC (NWBI)
Leaving: CEO – William W Harvey ( .3 yrs; )
Replaced by: Louis J Torchio

Mr. Torchio has been employed by Northwest Bank since 2018 and previously served as Senior Executive Vice President of Retail Lending of the Company and Northwest Bank. Mr. Torchio has 31 years of experience in the banking industry. Prior to joining the Company and Northwest Bank, Mr. Torchio held the position of Senior Vice President of Residential and Consumer Lending at Delaware County Bank for…read full bio

TITAN PHARMACEUTICALS INC (TTNP)
Leaving: CEO – Marc Rubin ( 1.8 yrs; -53.1% TSR)
Replaced by: David E Lazar

Mr. Lazar, age 32, has served as the Chief Executive Officer of Custodian Ventures LLC, a company which specializes in assisting distressed public companies through custodianship, since February 2018, and Activist Investing LLC, an actively managed investment fund, since March 2018. Previously, Mr. Lazar served as Managing Partner at Zenith Partners International Inc., a boutique consulting fir…read full bio

CFO Moves

ADT INC (ADT)
Leaving: CFO – Jeffrey Likosar ( 5.8 yrs; -6.2% TSR)
Replaced by: Kenneth Porpora

Mr. Porpora has served in roles of increasing responsibility with the Company, including his most recent role as Executive Vice President, Finance since May 2021; Senior Vice President, Chief Growth Officer from December 2018 to May 2021; President, Operations from August 2015 to December 2018; Chief Financial Officer of Residential Business at The ADT Corporation from October 2013 to August 2015;…read full bio

BROOKDALE SENIOR LIVING INC (BKD)
Leaving: CFO – Steven E Swain ( 3.9 yrs; -13.0% TSR)
Replaced by: Dawn L Kussow

Ms. Kussow will serve in such interim capacity until Mr. Swain returns. Ms. Kussow, age 48, joined the Company in 2007 and has served as Senior Vice President and Chief Accounting Officer of the Company since January 2016. Previously she served as the Company’s Vice President and Corporate Controller from February 2014 to January 2016 after serving in financial reporting leadership roles of escala…read full bio

COLICITY INC (COLI)
Leaving: CFO – Steve Ednie ( 1.8 yrs; -3.8% TSR)
Replaced by: Joseph J. Viraldo

Mr. Viraldo, age 39, has an extensive background in domestic and international accounting and tax matters, and currently serves as Director of Tax for Pendrell Corporation where he has worked since 2012. Mr. Viraldo began his professional career at Deloitte Tax LLP in the Lead Tax Services group. He holds M.S. and B.A. degrees in Accounting from Michigan State University and is a licensed Certi…read full bio

HARSCO CORP (HSC)
Leaving: CFO – Anshooman Aga ( 1.0 yrs; -68.3% TSR)
Replaced by: Pete Minan

Prior to his retirement from the Company in March 2022, Mr. Minan, age 60, served as the Company’s Senior Vice President & Chief Financial Officer from November 2014 to August 2021 and as Special Advisor to the Company’s Chief Executive Officer from August 2021 until March 2022….read full bio

INFINITE ACQUISITION CORP (NFNT)
Leaving: CFO – James Rosenstock ( .8 yrs; -2.4% TSR)
Replaced by: David Farber

Mr. Farber jointed LionTree LLC (“LionTree”) in January 2018 and serves as the Finance Director of LionTree since December 2020. In this role, Mr. Farber leads the firm on financial matters related to all aspects of LionTree’s business. Prior to LionTree, Mr. Farber worked at Avenue Capital Group from July 2013 to January 2018, focusing on domestic and international fund str…read full bio

RIOT BLOCKCHAIN INC (RIOT)
Leaving: CFO – Jefferey McGonegal ( 3.0 yrs; 50.8% TSR)
Replaced by: Colin Yee

Mr. Yee joined Riot as Head of Corporate & Financial Operations in April 2022. He is currently responsible for the overall coordination and scalability of the Company’s corporate and financial functions, including risk management, information technology, human resources and financial planning. Mr. Yee is an experienced business partner and team builder, having successfully grown…read full bio

Director Joins

ALLBIRDS INC (BIRD)
Ann Freeman

Ms. Freeman is an industry veteran and dynamic leader having spent over 26 years at Nike where she held multiple leadership positions in all key global markets. Most recently Ms. Freeman was Vice President and General Manager of North America, Nike’s largest market, where she led a …read full bio

BOX INC (BOX)
Amit Walia

Mr. Walia will serve as a Class I director whose term expires at the annual meeting of stockholders to be held in 2024. There are no arrangements or understandings between Mr. Walia, on the one hand, and the Company or any other persons, on the other hand, pursuant to which Mr. Walia was selected as…read full bio

LENDINGCLUB CORP (LC)
Syed Faiz Ahmad

Mr. Ahmad has more than two decades of expertise in leveraging technology to transform the customer experience for large consumer brands. He was CEO, Direct to Consumer at Optum, a subsidiary of United Health Group, and has also held leadership positions at Apple and Delta Airlines. He wi…read full bio

LENDINGCLUB CORP (LC)
Kathryn Reimann

Ms. Reimann spent more than two decades as a Chief Compliance Officer, most recently at Citibank, NA and before that, at American Express, and has advised other financial services and fintech companies on compliance risk management, bank regulatory and governance issues. Currently, she is…read full bio

MAGENTA THERAPEUTICS INC (MGTA)
Michael Vasconcelles

Dr. Vasconcelles has also entered into the Company’s standard form of indemnification agreement. Dr. Vasconcelles is a medical oncologist with more than 30 years of experience in research, medical operations, clinical trial design and strategic leadership in healthcare. From 2019 to 2022 he served a…read full bio

MALLINCKRODT PLC (MNKKQ)
Karen Ling

Karen L. Ling Karen L. Ling has been a director since August 2022. Ms. Ling most recently served as Executive Vice President and Chief Human Resources Officer for American International Group, Inc., a position she retired from in May 2021 and had held since July 2019. From March 2015 until July 201…read full bio

NORTHWEST BANCSHARES INC (NWBI)
William W Harvey

Mr. Harvey has been employed by the Company and Northwest Bank since 1996. Prior to his assuming the position of interim President and Chief Executive Officer, Mr. Harvey had served for 20 years as Chief Financial Officer. In connection with his increased responsibilities as Chief Operating Officer …read full bio

ONEWATER MARINE INC (ONEW)
J Steven Roy

J. Steven Roy. has served as an independent financial advisor since 2019, managing investment activities for a large family office. Prior to working independently, Mr. Roy was the Chief Financial Officer for AAA Cooper Transportation (“ACT”) from 2004 to 2019, a multi-regional logis…read full bio

SHOALS TECHNOLOGIES GROUP INC (SHLS)
Robert K Julian

Mr. Julian currently serves as Chief Financial Officer and Co-Interim Chief Executive Officer of The RealReal, Inc. (the “TheRealReal”) (Nasdaq: REAL), the world’s largest online marketplace for authenticated, consigned luxury goods, where he is responsible for developing and …read full bio

TITAN PHARMACEUTICALS INC (TTNP)
David E Lazar

Mr. Lazar, age 32, has served as the Chief Executive Officer of Custodian Ventures LLC, a company which specializes in assisting distressed public companies through custodianship, since February 2018, and Activist Investing LLC, an actively managed investment fund, since March 2018. Previously, M…read full bio

VOLITIONRX LTD (VNRX)
Mickie Henshall

Ms. Henshall, age 50, is a marketing executive with over 20 years’ experience in developing and implementing marketing and sales strategies for the IVD, clinical and life science markets.  Ms. Henshall currently serves as Chief Marketing Officer of REALM IDx, Inc. (formerly Konica Mino…read full bio

Director Exits

AKOUOS INC (AKUS)
Christopher M Smith ( 4.1 yrs; -59.0% TSR)
Committees: Nominating (and Governance)

ALLBIRDS INC (BIRD)
Nancy Green ( .8 yrs; -86.5% TSR)

AUTOLIV INC (ALV)
Min Liu ( 3.3 yrs; 3.0% TSR)
Committees: Audit, Audit and Risk, Leadership Development and Compensation

FATHOM HOLDINGS INC (FTHM)
Jeffrey H Coats ( 3.5 yrs; -16.2% TSR)
Committees: Audit, Compensation, Nominating (and Governance)

HELIOGEN INC (HLGN)
David W Crane ( .7 yrs; -84.9% TSR)

J M SMUCKER CO (SJM)
Timothy P Smucker ( 49.6 yrs; 10.2% TSR)

PYXUS INTERNATIONAL INC (PYXSQ)
Carl Hausmann ( 9.2 yrs; -49.4% TSR)

SHOALS TECHNOLOGIES GROUP INC (SHLS)
Peter Joseph Jonna ( 1.6 yrs; -20.7% TSR)

WEAVE COMMUNICATIONS INC (WEAV)
Roy Banks ( .8 yrs; -82.9% TSR)

ZIPRECRUITER INC (ZIP)
Emilie Choi ( 1.3 yrs; -9.6% TSR)

Recent Analysis

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.